期刊文献+

甲状腺癌中β_2—微球蛋白的原位表达

IN SITU EXPRESSION OF β_2-MICROGLOBULIN IN THYROID CARCINOMA
暂未订购
导出
摘要 我们应用免疫组化技术,研究比较了β2—微球蛋白在30例甲状腺癌和21例甲状腺良性病变中的表达,并且与甲状腺癌的一些特征进行了分析。几乎所有甲状腺良性病变对β2—微球蛋白均匀表达,强度与基质细胞相似,而甲状腺癌的表达明显不同,只有1例与甲状腺良性病变相似,9例完全丧失β2微球蛋白的表达。β2微球蛋白的表达丧失与分化差、已转移有关。本文提示β2—微球蛋白的表达丧失可支持恶性肿瘤的诊断。 Using immunohistochemistry, the epithelial expression of β 2-microglobulin was compared with in benign (21 cases) malignant (30 cases) thyroid The findings were compared with certain characteristics of the carcinomas. Almost all benign lesion epithelium expressed uniformly β2-microglobulin with similar intensity to the stromal ,cells Expression of β2-microglobulin by carcinoma was markly different Only one carcinoma stained in a manner akin to benign epithelium. Nine cases of carcinomas showed totally loss of expression. The poorer differentiated and metastasis of carcinoma were closely related to the loss of β 2-microglobulin expression. This study showed loss of β 2-microglobulin expression may support the malignant diagnosis.
出处 《癌症》 SCIE CAS CSCD 北大核心 1990年第4期280-281,285,共3页 Chinese Journal of Cancer
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部